The phrase "all a-gog" is correct and usable in written English.
It can be used to express excitement or eagerness about something that is about to happen or be revealed.
Example: "The children were all a-gog as they waited for the magician to start his show."
Alternatives: "all excited" or "full of anticipation".
I need you to help me with my blues ped-a-gog-y!' " Marsalis, who runs Jazz at Lincoln Center, arranged for Miller to give a concert and talk centered on T-Bone Walker, demonstrating what Miller called "the way to work your way around the guitar, T-Bone style".
Logistic regression examined probability of availability, eligibility and enrollment in a GOG trial.
The aim of this study was to identify patient and physician factors related to enrollment onto Gynecologic Oncology Group GOGG) trials.Prospective study of women with primary or recurrent cancer of the uterus or cervix treated at a GOG institution from July 2010 to January 2012.
However, a GOG randomised trial of women with advanced or recurrent endometrial carcinoma, in which the combination paclitaxel−doxorubicin was compared with doxorubicin−cisplatin, showed that the paclitaxel arm did not result in an improved outcome (Fleming et al, 2000).
A GOG study to compare the combination of TC with TAP GOGG #209) has finished recruitment of the patients; however, analysis of the survival effects of the two regimens may require a few years; a similar JGOG study to compare the combination chemotherapies TC, DP and AP JGOGG #2043) is even less far along; it is still under registration of patients.
However, these results were contradicted by a further GOG trial, GOG-132 (Muggia et al, 1997, 2000), comparing single agent cisplatin against the same paclitaxel/cisplatin combination used in GOG-111, with 424 patients randomised between these two arms (648 randomised in total between three arms, with the third arm being single agent paclitaxel).
METHODS: Patients with recurrent carcinosarcoma of the uterus who had failed one regimen of chemotherapy, had a Gynecologic Oncology Group (GOG) performance status of 0-2 and had measurable disease were included.
Disparities were arbitrated by a third GOG pathologist.
Confirmatory prospective randomised trials of UAPI are therefore unlikely to be feasible, although we are exploring this possibility within a planned GOG study.
A prospective GOG trial of adjuvant cisplatin and cyclophosphamide with or without doxorubicin examined the effect of delay in the initiation of treatment and outcome for 349 patients with stage III OC.
A recent GOG-161 study comparing ifosfamide+paclitaxel vs single-agent ifosfamide yielded significantly better RRs (45 vs 29%), prolongation in median progression-free survival (PFS) (5.8 vs 3.6 months) and OS (13.5 vs 8.4 months) (Homesley et al, 2007).
